Figure 6
PolyP only affects lysis if present during polymerization of fibrinogen. (A) Fibrin clots were formed from fibrinogen (2.4μM), plasminogen (0.24μM), and tPA (20pM) in the absence (gray line) and presence (black line) of polyP65 (325μM) by adding atroxin (10 μg/mL) and CaCl2 (5mM; n = 4). (B) Soluble fibrin was repolymerized in the presence of plasminogen (0.24μM) and tPA (20pM) in the absence (gray line) and presence (black line) of polyP 65 (325μM; n = 5). (C) Clots were generated with purified fibrinogen clotted with (black line) and without (pale gray line) polyP65 (325μM). Clots were incubated for 30 minutes at 37°C before overlaying with a mixture of plasminogen (0.55μM) and tPA (10nM) with (dark gray line) and without polyP65 (325μM; n = 8). Results are normalized and expressed as the mean ± SEM.

PolyP only affects lysis if present during polymerization of fibrinogen. (A) Fibrin clots were formed from fibrinogen (2.4μM), plasminogen (0.24μM), and tPA (20pM) in the absence (gray line) and presence (black line) of polyP65 (325μM) by adding atroxin (10 μg/mL) and CaCl2 (5mM; n = 4). (B) Soluble fibrin was repolymerized in the presence of plasminogen (0.24μM) and tPA (20pM) in the absence (gray line) and presence (black line) of polyP 65 (325μM; n = 5). (C) Clots were generated with purified fibrinogen clotted with (black line) and without (pale gray line) polyP65 (325μM). Clots were incubated for 30 minutes at 37°C before overlaying with a mixture of plasminogen (0.55μM) and tPA (10nM) with (dark gray line) and without polyP65 (325μM; n = 8). Results are normalized and expressed as the mean ± SEM.

Close Modal

or Create an Account

Close Modal
Close Modal